|
Sonoscape Medical Corp. (300633.SZ) Évaluation DCF
CN | Healthcare | Medical - Devices | SHZ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
SonoScape Medical Corp. (300633.SZ) Bundle
Améliorez vos stratégies d'investissement avec la calculatrice DCF de Sonoscape Medical Corp. (300633SZ)! Utilisez des données financières authentiques de Sonoscape, ajustez les projections et dépenses de croissance et observez instantanément comment ces modifications affectent la valeur intrinsèque de Sonoscape Medical Corp. (300633SZ).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,253.9 | 1,163.1 | 1,444.6 | 1,762.6 | 2,120.3 | 2,434.4 | 2,795.1 | 3,209.3 | 3,684.8 | 4,230.8 |
| Revenue Growth, % | 0 | -7.24 | 24.2 | 22.02 | 20.29 | 14.82 | 14.82 | 14.82 | 14.82 | 14.82 |
| EBITDA | 154.6 | 8.8 | 319.9 | 439.0 | 544.9 | 417.9 | 479.9 | 551.0 | 632.6 | 726.4 |
| EBITDA, % | 12.33 | 0.75338 | 22.15 | 24.91 | 25.7 | 17.17 | 17.17 | 17.17 | 17.17 | 17.17 |
| Depreciation | 29.2 | 33.3 | 57.8 | 57.5 | 66.0 | 75.8 | 87.0 | 99.9 | 114.7 | 131.7 |
| Depreciation, % | 2.33 | 2.86 | 4 | 3.26 | 3.11 | 3.11 | 3.11 | 3.11 | 3.11 | 3.11 |
| EBIT | 125.5 | -24.5 | 262.1 | 381.5 | 478.9 | 342.1 | 392.8 | 451.1 | 517.9 | 594.6 |
| EBIT, % | 10.01 | -2.11 | 18.14 | 21.64 | 22.59 | 14.05 | 14.05 | 14.05 | 14.05 | 14.05 |
| Total Cash | 857.0 | 899.6 | 1,414.7 | 1,756.7 | 1,826.0 | 2,090.7 | 2,400.5 | 2,756.2 | 3,164.6 | 3,633.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 357.6 | 248.0 | 210.1 | 200.1 | 174.2 | 408.8 | 469.3 | 538.9 | 618.7 | 710.4 |
| Account Receivables, % | 28.52 | 21.32 | 14.54 | 11.35 | 8.22 | 16.79 | 16.79 | 16.79 | 16.79 | 16.79 |
| Inventories | 288.1 | 310.7 | 440.5 | 514.4 | 531.5 | 654.5 | 751.5 | 862.9 | 990.7 | 1,137.5 |
| Inventories, % | 22.98 | 26.71 | 30.49 | 29.18 | 25.07 | 26.89 | 26.89 | 26.89 | 26.89 | 26.89 |
| Accounts Payable | 195.2 | 135.3 | 231.5 | 231.4 | 186.1 | 317.1 | 364.1 | 418.1 | 480.0 | 551.1 |
| Accounts Payable, % | 15.57 | 11.63 | 16.03 | 13.13 | 8.78 | 13.03 | 13.03 | 13.03 | 13.03 | 13.03 |
| Capital Expenditure | -158.8 | -155.3 | -152.2 | -190.3 | -177.0 | -271.2 | -311.4 | -357.5 | -410.5 | -471.3 |
| Capital Expenditure, % | -12.66 | -13.35 | -10.54 | -10.8 | -8.35 | -11.14 | -11.14 | -11.14 | -11.14 | -11.14 |
| Tax Rate, % | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 |
| EBITAT | 118.3 | -25.5 | 254.9 | 369.4 | 459.3 | 331.4 | 380.5 | 436.9 | 501.6 | 575.9 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -461.8 | -120.4 | 164.8 | 172.7 | 311.8 | -90.6 | 45.6 | 52.3 | 60.1 | 69.0 |
| WACC, % | 5.35 | 5.36 | 5.36 | 5.35 | 5.35 | 5.35 | 5.35 | 5.35 | 5.35 | 5.35 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 101.7 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | 71 | |||||||||
| Terminal Value | 3,849 | |||||||||
| Present Terminal Value | 2,966 | |||||||||
| Enterprise Value | 3,067 | |||||||||
| Net Debt | -1,702 | |||||||||
| Equity Value | 4,770 | |||||||||
| Diluted Shares Outstanding, MM | 433 | |||||||||
| Equity Value Per Share | 11.02 |
Benefits You Will Receive
- Adjustable Forecast Inputs: Effortlessly modify key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: SonoScape Medical Corp.’s financial data pre-inserted to kickstart your evaluation.
- Automated DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
- Professional and Customizable: A refined Excel model tailored to meet your valuation requirements.
- Designed for Analysts and Investors: Perfect for analyzing projections, assessing strategies, and increasing efficiency.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for SonoScape Medical Corp. (300633SZ).
- WACC Calculator: A pre-configured Weighted Average Cost of Capital tool with adjustable input parameters specific to (300633SZ).
- Customizable Forecast Assumptions: Easily adjust growth rates, capital expenditures, and discount rates for precise modeling.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios for SonoScape Medical Corp. (300633SZ).
- Interactive Dashboard and Charts: Visual representations to summarize key valuation metrics, facilitating straightforward analysis.
How It Works
- Step 1: Download the prebuilt Excel template featuring SonoScape Medical Corp. (300633SZ) data.
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with the key metrics.
- Step 3: Update the forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see recalculated outcomes, including SonoScape Medical Corp.'s (300633SZ) intrinsic value.
- Step 5: Utilize the results to make informed investment decisions or create comprehensive reports.
Why Opt for the SonoScape Medical Corp. ([300633SZ]) Calculator?
- Reliable Data: Authentic SonoScape financials guarantee trustworthy valuation outcomes.
- Adjustable Settings: Tailor essential factors like growth rates, WACC, and tax rates to fit your forecasts.
- Efficiency Boost: Pre-configured calculations save you the trouble of starting from scratch.
- Professional-Quality Tool: Crafted for investors, analysts, and consultants alike.
- Easy to Use: User-friendly design and clear, step-by-step guidance ensure accessibility for everyone.
Who Can Benefit from SonoScape Medical Corp. (300633SZ)?
- Investors: Assess the valuation of SonoScape before making investment decisions.
- CFOs and Financial Analysts: Optimize valuation methodologies and validate financial forecasts.
- Startup Founders: Understand the valuation strategies of established medical technology firms like SonoScape.
- Consultants: Provide expert valuation insights and reports to your clients.
- Students and Educators: Utilize real case studies to learn and teach valuation principles.
Contents of the Template
- Comprehensive DCF Model: An editable template featuring intricate valuation calculations.
- Real-World Data: SonoScape Medical Corp.'s (300633SZ) historical and projected financials are preloaded for your analysis.
- Customizable Parameters: Tailor WACC, growth rates, and tax assumptions to explore different scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for in-depth insights.
- Key Ratios: Integrated analysis covering profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Visual charts and tables present clear, actionable results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.